An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
CG Oncology, Inc.
CG Oncology, Inc.
xCures
ImmunityBio, Inc.
AVM Biotechnology Inc
Telix Pharmaceuticals (Innovations) Pty Limited
Pfizer
UroGen Pharma Ltd.
Agenus Inc.
Matrix Biomed, Inc.